Persistent heel pain, often plantar-fasciitis-related, used as a broader diagnostic label.
Chronic plantar heel pain (CPHP) refers to pain under the heel that has persisted beyond the acute phase, typically defined by a duration threshold (commonly around a month or longer, though exact cut-offs vary between studies) rather than a specific timeframe agreed across all literature. It is used as a deliberately broad label rather than a diagnosis tied to one structure, most often associated with plantar fascia pathology but not assumed to arise from the fascia alone in every case. The term is favoured in research to group persistent presentations together while acknowledging that the underlying tissue driver may differ between patients.
Labelling a presentation as chronic rather than acute changes the conversation with the patient and the expected trajectory: chronic cases generally respond more slowly, need longer-term management planning, and warrant screening for contributing factors beyond local mechanics. It also flags to the clinician that a single-structure, single-intervention approach (e.g. treating it purely as fasciitis) may be too narrow, since persistence can be influenced by biomechanical load, tissue degeneration, and systemic factors together.
In practice this remains a clinical diagnosis built on history (duration, pain pattern, aggravating load) and examination findings such as palpation tenderness at the medial calcaneal tubercle, first-step pain, and response to loading tests, with imaging reserved for atypical or non-resolving cases. Duration of symptoms is the key feature distinguishing CPHP from acute presentations, so a clear timeline from the patient is essential, and clinicians increasingly consider metabolic or lipid-related risk factors (e.g. in patients with relevant comorbidities) as part of a fuller assessment when pain is protracted or atypical.
Because CPHP is an umbrella term, it can be mistaken for a specific diagnosis, leading clinicians to assume plantar fascia involvement without confirming it, when other structures or contributors may be relevant. The evidence on systemic factors such as metabolic and lipid profiles is still emerging and associative rather than clearly causal, so these should inform a broader assessment rather than replace standard biomechanical and load-based evaluation.
This guide was auto-drafted and is pending editorial review.